telmisartan and hydrochlorothiazide

Product NDC: 0054-0547
11-digit product format: 000540547
Labeler code: 0054
Product ID: 0054-0547_426556da-fe30-4161-9845-e1a7dfbeafda
Type: HUMAN PRESCRIPTION DRUG
Nonproprietary name: telmisartan and hydrochlorothiazide
Dosage form: TABLET
Route: ORAL
Labeler: Hikma Pharmaceuticals USA Inc.
Application: NDA021162
Marketing category: NDA AUTHORIZED GENERIC
Marketing start: 2014-02-28
Marketing end: 2022-11-30
Substance: TELMISARTAN; HYDROCHLOROTHIAZIDE
Active strength: 80 mg/1; mg/1
Pharmacologic classes: Angiotensin 2 Receptor Antagonists [MoA],Angiotensin 2 Receptor Blocker [EPC],Increased Diuresis [PE],Thiazide Diuretic [EPC],Thiazides [CS]
NDC exclude flag: No
Listing certified through: 0000-00-00
Current FDA listing: Historical FDA.report record

NDC auxiliary status#

Explicit status records from FDA unfinished, excluded, and compounder auxiliary files. Absence of a row is not itself a regulatory status. Browse every current auxiliary row, including rows without a usable NDC. · Browse every captured source and parsed snapshot.

Current NDC status page 1 of 1 · 2 matching rows.

Dataset, Scope, Product NDC table
Dataset	Scope	Product NDC	Package NDC	Code	Status	Reporting period	Source date
excluded product	product	0054-0547		D	Discontinued by firm		2026-08-03
excluded package	package	0054-0547	0054-0547-18	D	Discontinued by firm		2026-08-03

Observed NDC auxiliary status history#

Observed captured status history: Rows come only from successfully parsed FDA auxiliary ZIP captures. They show the state present in that artifact, not a continuous regulatory timeline. Absence before, after, or between captures is not proof of status, and a known non-data HTTP 403 capture is preserved in backfill provenance but cannot produce a status row.

Historic NDC status page 1 of 1 · 10 matching rows.

Browse every current auxiliary row. · Browse the complete NDC auxiliary source catalog.

Captured / source date, Dataset, Scope table
Captured / source date	Dataset	Scope	Product NDC	Package NDC	Code	Status	Archive	Snapshot	Source SHA-256
2025-01-20 13:05 UTC · source 2025-01-20	excluded product	product	0054-0547		D	Discontinued by firm	excluded / ndc_excluded.zip	`ed331223b511…`	`672a5bd82f5f…`
2025-01-20 13:05 UTC · source 2025-01-20	excluded package	package	0054-0547	0054-0547-18	D	Discontinued by firm	excluded / ndc_excluded.zip	`ed331223b511…`	`672a5bd82f5f…`
2025-01-11 03:41 UTC · source 2025-01-10	excluded product	product	0054-0547		D	Discontinued by firm	excluded / ndc_excluded.zip	`0efc9e666f02…`	`f202fb6c5f17…`
2025-01-11 03:41 UTC · source 2025-01-10	excluded package	package	0054-0547	0054-0547-18	D	Discontinued by firm	excluded / ndc_excluded.zip	`0efc9e666f02…`	`f202fb6c5f17…`
2024-11-09 02:27 UTC · source 2024-11-08	excluded product	product	0054-0547		D	Discontinued by firm	excluded / ndc_excluded.zip	`ad56d346431e…`	`cc804d4bbf1e…`
2024-11-09 02:27 UTC · source 2024-11-08	excluded package	package	0054-0547	0054-0547-18	D	Discontinued by firm	excluded / ndc_excluded.zip	`ad56d346431e…`	`cc804d4bbf1e…`
2024-10-04 04:10 UTC · source 2024-10-03	excluded product	product	0054-0547		D	Discontinued by firm	excluded / ndc_excluded.zip	`367a005e9d99…`	`383a685ebd0f…`
2024-10-04 04:10 UTC · source 2024-10-03	excluded package	package	0054-0547	0054-0547-18	D	Discontinued by firm	excluded / ndc_excluded.zip	`367a005e9d99…`	`383a685ebd0f…`
2024-07-10 04:00 UTC · source 2024-07-09	excluded product	product	0054-0547		D	Discontinued by firm	excluded / ndc_excluded.zip	`557ba5c1ecfa…`	`9c80585c8c6e…`
2024-07-10 04:00 UTC · source 2024-07-09	excluded package	package	0054-0547	0054-0547-18	D	Discontinued by firm	excluded / ndc_excluded.zip	`557ba5c1ecfa…`	`9c80585c8c6e…`

Source provenance: Browse the complete Orange Book source catalog · source snapshot 1.

Orange Book products#

Current product rows page 1 of 1 · 3 matching rows.

Application-product, Trade name, Ingredient table
Application-product	Trade name	Ingredient	Strength	Dosage form / route	TE codes	RLD / RS	Approval date
N021162-001	MICARDIS HCT	HYDROCHLOROTHIAZIDE; TELMISARTAN	12.5MG;40MG	TABLET / ORAL	AB	RLD	2000-11-17
N021162-002	MICARDIS HCT	HYDROCHLOROTHIAZIDE; TELMISARTAN	12.5MG;80MG	TABLET / ORAL	AB	RLD	2000-11-17
N021162-003	MICARDIS HCT	HYDROCHLOROTHIAZIDE; TELMISARTAN	25MG;80MG	TABLET / ORAL	AB	RLD, RS	2004-04-19

Therapeutic equivalence codes#

Current TE-code rows page 1 of 1 · 3 matching rows.

Application-product, TE code table
Application-product	TE code
N021162-001	AB
N021162-002	AB
N021162-003	AB

Observed Orange Book product history#

Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.

Product history page 1 of 4 · 123 observed states.

Captured, Edition, Application-product table
Captured	Edition	Application-product	Trade name	Strength	Dosage form / route	Product TE source text	RLD / RS	Approval date	Source SHA-256
2026-02-19 14:30 UTC	2026-02	N021162-001	MICARDIS HCT	12.5MG;40MG	TABLET / ORAL	AB	RLD	2000-11-17	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	N021162-002	MICARDIS HCT	12.5MG;80MG	TABLET / ORAL	AB	RLD	2000-11-17	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	N021162-003	MICARDIS HCT	25MG;80MG	TABLET / ORAL	AB	RLD, RS	2004-04-19	`011fe1cb6892…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	N021162-001	MICARDIS HCT	12.5MG;40MG	TABLET / ORAL	AB	RLD	2000-11-17	`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	N021162-002	MICARDIS HCT	12.5MG;80MG	TABLET / ORAL	AB	RLD	2000-11-17	`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	N021162-003	MICARDIS HCT	25MG;80MG	TABLET / ORAL	AB	RLD, RS	2004-04-19	`31067a03dcf5…`
2025-08-23 18:47 UTC	2025-08	N021162-001	MICARDIS HCT	12.5MG;40MG	TABLET / ORAL	AB	RLD	2000-11-17	`6a471c1ec25d…`
2025-08-23 18:47 UTC	2025-08	N021162-002	MICARDIS HCT	12.5MG;80MG	TABLET / ORAL	AB	RLD	2000-11-17	`6a471c1ec25d…`
2025-08-23 18:47 UTC	2025-08	N021162-003	MICARDIS HCT	25MG;80MG	TABLET / ORAL	AB	RLD, RS	2004-04-19	`6a471c1ec25d…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	N021162-001	MICARDIS HCT	12.5MG;40MG	TABLET / ORAL	AB	RLD	2000-11-17	`fd3edfee7708…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	N021162-002	MICARDIS HCT	12.5MG;80MG	TABLET / ORAL	AB	RLD	2000-11-17	`fd3edfee7708…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	N021162-003	MICARDIS HCT	25MG;80MG	TABLET / ORAL	AB	RLD, RS	2004-04-19	`fd3edfee7708…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	N021162-001	MICARDIS HCT	12.5MG;40MG	TABLET / ORAL	AB	RLD	2000-11-17	`b8a1b40f171c…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	N021162-002	MICARDIS HCT	12.5MG;80MG	TABLET / ORAL	AB	RLD	2000-11-17	`b8a1b40f171c…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	N021162-003	MICARDIS HCT	25MG;80MG	TABLET / ORAL	AB	RLD, RS	2004-04-19	`b8a1b40f171c…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	N021162-001	MICARDIS HCT	12.5MG;40MG	TABLET / ORAL	AB	RLD	2000-11-17	`03ed91905a0d…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	N021162-002	MICARDIS HCT	12.5MG;80MG	TABLET / ORAL	AB	RLD	2000-11-17	`03ed91905a0d…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	N021162-003	MICARDIS HCT	25MG;80MG	TABLET / ORAL	AB	RLD, RS	2004-04-19	`03ed91905a0d…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	N021162-001	MICARDIS HCT	12.5MG;40MG	TABLET / ORAL	AB	RLD	2000-11-17	`2680178bc6a6…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	N021162-002	MICARDIS HCT	12.5MG;80MG	TABLET / ORAL	AB	RLD	2000-11-17	`2680178bc6a6…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	N021162-003	MICARDIS HCT	25MG;80MG	TABLET / ORAL	AB	RLD, RS	2004-04-19	`2680178bc6a6…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	N021162-001	MICARDIS HCT	12.5MG;40MG	TABLET / ORAL	AB	RLD	2000-11-17	`5bbf6a4d5a75…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	N021162-002	MICARDIS HCT	12.5MG;80MG	TABLET / ORAL	AB	RLD	2000-11-17	`5bbf6a4d5a75…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	N021162-003	MICARDIS HCT	25MG;80MG	TABLET / ORAL	AB	RLD, RS	2004-04-19	`5bbf6a4d5a75…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	N021162-001	MICARDIS HCT	12.5MG;40MG	TABLET / ORAL	AB	RLD	2000-11-17	`d8e5a09893c0…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	N021162-002	MICARDIS HCT	12.5MG;80MG	TABLET / ORAL	AB	RLD	2000-11-17	`d8e5a09893c0…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	N021162-003	MICARDIS HCT	25MG;80MG	TABLET / ORAL	AB	RLD, RS	2004-04-19	`d8e5a09893c0…`
2024-10-29 15:01 UTC	2024-10	N021162-001	MICARDIS HCT	12.5MG;40MG	TABLET / ORAL	AB	RLD	2000-11-17	`d06236e962d9…`
2024-10-29 15:01 UTC	2024-10	N021162-002	MICARDIS HCT	12.5MG;80MG	TABLET / ORAL	AB	RLD	2000-11-17	`d06236e962d9…`
2024-10-29 15:01 UTC	2024-10	N021162-003	MICARDIS HCT	25MG;80MG	TABLET / ORAL	AB	RLD, RS	2004-04-19	`d06236e962d9…`
2024-08-13 05:28 UTC · 3 captures of this ZIP	2024-08	N021162-001	MICARDIS HCT	12.5MG;40MG	TABLET / ORAL	AB	RLD	2000-11-17	`79d66fd596c7…`
2024-08-13 05:28 UTC · 3 captures of this ZIP	2024-08	N021162-002	MICARDIS HCT	12.5MG;80MG	TABLET / ORAL	AB	RLD	2000-11-17	`79d66fd596c7…`
2024-08-13 05:28 UTC · 3 captures of this ZIP	2024-08	N021162-003	MICARDIS HCT	25MG;80MG	TABLET / ORAL	AB	RLD, RS	2004-04-19	`79d66fd596c7…`
2024-07-13 05:37 UTC · 2 captures of this ZIP	2024-07	N021162-001	MICARDIS HCT	12.5MG;40MG	TABLET / ORAL	AB	RLD	2000-11-17	`301d65b070ca…`
2024-07-13 05:37 UTC · 2 captures of this ZIP	2024-07	N021162-002	MICARDIS HCT	12.5MG;80MG	TABLET / ORAL	AB	RLD	2000-11-17	`301d65b070ca…`
2024-07-13 05:37 UTC · 2 captures of this ZIP	2024-07	N021162-003	MICARDIS HCT	25MG;80MG	TABLET / ORAL	AB	RLD, RS	2004-04-19	`301d65b070ca…`
2024-06-18 03:08 UTC · 5 captures of this ZIP	2024-06	N021162-001	MICARDIS HCT	12.5MG;40MG	TABLET / ORAL	AB	RLD	2000-11-17	`1e350fbaab3a…`
2024-06-18 03:08 UTC · 5 captures of this ZIP	2024-06	N021162-002	MICARDIS HCT	12.5MG;80MG	TABLET / ORAL	AB	RLD	2000-11-17	`1e350fbaab3a…`
2024-06-18 03:08 UTC · 5 captures of this ZIP	2024-06	N021162-003	MICARDIS HCT	25MG;80MG	TABLET / ORAL	AB	RLD, RS	2004-04-19	`1e350fbaab3a…`
2024-05-31 18:47 UTC	2024-05	N021162-001	MICARDIS HCT	12.5MG;40MG	TABLET / ORAL	AB	RLD	2000-11-17	`8072bd15b7f6…`

Observed Orange Book normalized TE history#

Normalized TE history page 1 of 4 · 123 observed states.

Captured, Edition, Application-product table
Captured	Edition	Application-product	TE code	Order	Source SHA-256
2026-02-19 14:30 UTC	2026-02	N021162-001	AB	1	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	N021162-002	AB	1	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	N021162-003	AB	1	`011fe1cb6892…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	N021162-001	AB	1	`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	N021162-002	AB	1	`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	N021162-003	AB	1	`31067a03dcf5…`
2025-08-23 18:47 UTC	2025-08	N021162-001	AB	1	`6a471c1ec25d…`
2025-08-23 18:47 UTC	2025-08	N021162-002	AB	1	`6a471c1ec25d…`
2025-08-23 18:47 UTC	2025-08	N021162-003	AB	1	`6a471c1ec25d…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	N021162-001	AB	1	`fd3edfee7708…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	N021162-002	AB	1	`fd3edfee7708…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	N021162-003	AB	1	`fd3edfee7708…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	N021162-001	AB	1	`b8a1b40f171c…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	N021162-002	AB	1	`b8a1b40f171c…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	N021162-003	AB	1	`b8a1b40f171c…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	N021162-001	AB	1	`03ed91905a0d…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	N021162-002	AB	1	`03ed91905a0d…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	N021162-003	AB	1	`03ed91905a0d…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	N021162-001	AB	1	`2680178bc6a6…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	N021162-002	AB	1	`2680178bc6a6…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	N021162-003	AB	1	`2680178bc6a6…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	N021162-001	AB	1	`5bbf6a4d5a75…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	N021162-002	AB	1	`5bbf6a4d5a75…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	N021162-003	AB	1	`5bbf6a4d5a75…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	N021162-001	AB	1	`d8e5a09893c0…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	N021162-002	AB	1	`d8e5a09893c0…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	N021162-003	AB	1	`d8e5a09893c0…`
2024-10-29 15:01 UTC	2024-10	N021162-001	AB	1	`d06236e962d9…`
2024-10-29 15:01 UTC	2024-10	N021162-002	AB	1	`d06236e962d9…`
2024-10-29 15:01 UTC	2024-10	N021162-003	AB	1	`d06236e962d9…`
2024-08-13 05:28 UTC · 3 captures of this ZIP	2024-08	N021162-001	AB	1	`79d66fd596c7…`
2024-08-13 05:28 UTC · 3 captures of this ZIP	2024-08	N021162-002	AB	1	`79d66fd596c7…`
2024-08-13 05:28 UTC · 3 captures of this ZIP	2024-08	N021162-003	AB	1	`79d66fd596c7…`
2024-07-13 05:37 UTC · 2 captures of this ZIP	2024-07	N021162-001	AB	1	`301d65b070ca…`
2024-07-13 05:37 UTC · 2 captures of this ZIP	2024-07	N021162-002	AB	1	`301d65b070ca…`
2024-07-13 05:37 UTC · 2 captures of this ZIP	2024-07	N021162-003	AB	1	`301d65b070ca…`
2024-06-18 03:08 UTC · 5 captures of this ZIP	2024-06	N021162-001	AB	1	`1e350fbaab3a…`
2024-06-18 03:08 UTC · 5 captures of this ZIP	2024-06	N021162-002	AB	1	`1e350fbaab3a…`
2024-06-18 03:08 UTC · 5 captures of this ZIP	2024-06	N021162-003	AB	1	`1e350fbaab3a…`
2024-05-31 18:47 UTC	2024-05	N021162-001	AB	1	`8072bd15b7f6…`

Observed Orange Book patent history#

Captured, Edition, Application-product table
Captured	Edition	Application-product	Patent	Expiration	Source SHA-256
2019-12-13 00:20 UTC	2019-12	N021162-001	6358986	2020-01-10	`74a2ff9319b5…`
2019-12-13 00:20 UTC	2019-12	N021162-002	6358986	2020-01-10	`74a2ff9319b5…`
2020-12-22 03:56 UTC	2020-12	N021162-001	6358986	2020-01-10	`8869cabd3fbd…`
2020-12-22 03:56 UTC	2020-12	N021162-002	6358986	2020-01-10	`8869cabd3fbd…`
2020-11-12 02:37 UTC	2020-11	N021162-001	6358986	2020-01-10	`c0c555d07b60…`
2020-11-12 02:37 UTC	2020-11	N021162-002	6358986	2020-01-10	`c0c555d07b60…`
2019-12-14 00:12 UTC	2019-12	N021162-001	6358986	2020-01-10	`3f01610625f2…`
2019-12-14 00:12 UTC	2019-12	N021162-002	6358986	2020-01-10	`3f01610625f2…`
2019-09-15 20:21 UTC	2019-09	N021162-001	6358986	2020-01-10	`b00525d2431f…`
2019-09-15 20:21 UTC	2019-09	N021162-002	6358986	2020-01-10	`b00525d2431f…`
2019-07-19 19:46 UTC	2019-07	N021162-001	6358986	2020-01-10	`ea99ee380514…`
2019-07-19 19:46 UTC	2019-07	N021162-002	6358986	2020-01-10	`ea99ee380514…`

openFDA label cross-check#

Cross-check layer: openFDA label JSON enriches search and identifies hydration gaps. The DailyMed Structured Product Label remains the canonical label presentation on FDA.report. Every label matching the complete exact-identifier union is deduplicated and paginated below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
Brand	Generic	Manufacturer	SPL set ID	Effective date	Available safety fields	Join
Micardis HCT	TELMISARTAN AND HYDROCHLOROTHIAZIDE	Boehringer Ingelheim Pharmaceuticals, Inc.	b078dae2-664d-4144-847a-3b9d9b557402	2024-12-31	Boxed warning, Warnings, Adverse reactions	Exact identifier application applno (NDA): 021162 application number: NDA021162

DailyMed Billing Units#

Package NDC, Billing unit, Product NDC table
Package NDC	Billing unit	Product NDC	DailyMed indexing SPL	SPL version	Effective
0054-0547-18	EA - Each	0054-0547	d9c8983d-4b75-42cf-b0e4-65dd39e127bb	1	2014-04-03

DailyMed Socrata Ingredients#

Ingredient, Type, UNII table
Ingredient	Type	UNII	DailyMed label	SPL version
HYDROCHLOROTHIAZIDE	ACTIVE INGREDIENT	0J48LPH2TH	TELMISARTAN AND HYDROCHLOROTHIAZIDE TABLET [ROXANE LABORATORIES, INC.]	2
TELMISARTAN	ACTIVE INGREDIENT	U5SYW473RQ	TELMISARTAN AND HYDROCHLOROTHIAZIDE TABLET [ROXANE LABORATORIES, INC.]	2
HYDROCHLOROTHIAZIDE	ACTIVE MOIETY	0J48LPH2TH	TELMISARTAN AND HYDROCHLOROTHIAZIDE TABLET [ROXANE LABORATORIES, INC.]	2
TELMISARTAN	ACTIVE MOIETY	U5SYW473RQ	TELMISARTAN AND HYDROCHLOROTHIAZIDE TABLET [ROXANE LABORATORIES, INC.]	2

UNII, Preferred term, Registry number table
UNII	Preferred term	Registry number	Matched term
U5SYW473RQ	TELMISARTAN	144701-48-4	TELMISARTAN
0J48LPH2TH	HYDROCHLOROTHIAZIDE	58-93-5	HYDROCHLOROTHIAZIDE

Packages#

Package NDC, 11-digit format, Description table
Package NDC	11-digit format	Description	Units	Marketing start	Marketing end	Sample	Exclude flag	Status
0054-0547-18	00054054718	3 BLISTER PACK in 1 CARTON (0054-0547-18) > 10 TABLET in 1 BLISTER PACK	3 blister pack	2014-02-28	0000-00-00	No	No	Current

Title, Manufacturer, Effective date table
Title	Manufacturer	Effective date	Type	Version
telmisartan and hydrochlorothiazide	Hikma Pharmaceuticals USA Inc. \| Boehringer Ingelheim Pharma GMbH and Co. KG	2021-07-15	HUMAN PRESCRIPTION DRUG LABEL	6